ZA898553B - The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c - Google Patents

The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c

Info

Publication number
ZA898553B
ZA898553B ZA898553A ZA898553A ZA898553B ZA 898553 B ZA898553 B ZA 898553B ZA 898553 A ZA898553 A ZA 898553A ZA 898553 A ZA898553 A ZA 898553A ZA 898553 B ZA898553 B ZA 898553B
Authority
ZA
South Africa
Prior art keywords
protein kinase
calmodulin
inhibitor
calcium
ethylenediaminetetraacetic acid
Prior art date
Application number
ZA898553A
Inventor
Ferdinand Hucho
Hucho Ferdinand
Iris Pribilla
Pribilla Iris
Werner Schiebler
Schiebler Werner
Dominique Tripier
Tripier Dominique
Herbert Kogler
Kogler Herbert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA898553B publication Critical patent/ZA898553B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA898553A 1988-11-10 1989-11-09 The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c ZA898553B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3838068 1988-11-10

Publications (1)

Publication Number Publication Date
ZA898553B true ZA898553B (en) 1990-08-29

Family

ID=6366838

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898553A ZA898553B (en) 1988-11-10 1989-11-09 The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c

Country Status (11)

Country Link
EP (1) EP0368223A3 (en)
JP (1) JPH02180818A (en)
KR (1) KR900007410A (en)
CN (1) CN1042545A (en)
AU (1) AU617892B2 (en)
CA (1) CA2002637A1 (en)
DE (1) DE3937015A1 (en)
DK (1) DK560989A (en)
HU (1) HU204195B (en)
PT (1) PT92281A (en)
ZA (1) ZA898553B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112103C2 (en) * 1991-02-18 1994-07-14 Matthias Mueller Use of acetic acid to regulate blood sugar levels
WO1998007415A2 (en) * 1996-08-20 1998-02-26 Novartis Ag Methods for prevention of cellular proliferation and restenosis
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
DE10138912A1 (en) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
HU229104B1 (en) 2007-11-22 2013-07-29 Pharmateka Bt Use of edta and its salts for the prevention and treatment of bacterial intestinal swine diseases caused by brachyspira hyodysenteriae and for enhancement of efficiency of antibiotics in curing such illnesses
EE05628B1 (en) 2010-12-23 2013-02-15 Tallinna Tehnikaülikool Composite polymeric material with mineral fillers
CN111450085A (en) * 2020-05-22 2020-07-28 颜廷良 Broad-spectrum anti-tumor medicine and preparation method and application thereof

Also Published As

Publication number Publication date
DK560989D0 (en) 1989-11-09
DK560989A (en) 1990-05-11
EP0368223A2 (en) 1990-05-16
AU4450489A (en) 1990-05-17
CA2002637A1 (en) 1990-05-10
JPH02180818A (en) 1990-07-13
HU895861D0 (en) 1990-02-28
PT92281A (en) 1990-05-31
KR900007410A (en) 1990-06-01
CN1042545A (en) 1990-05-30
HUT51893A (en) 1990-06-28
AU617892B2 (en) 1991-12-05
DE3937015A1 (en) 1990-05-17
HU204195B (en) 1991-12-30
EP0368223A3 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
PH30794A (en) Inhibition of phosphatidylinositol 3-kinase with worthmannin and analogs thereof.
PT92627A (en) TIGHTENING CONNECTION SUSCEPTIVEL OF BEING UNCERTAINED
EG18081A (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as the use indurugs
SG53193G (en) Deodorizer for refrigerators of the like
ZA931935B (en) Preparation of substituted guanidines
JPS6447799A (en) Tissue factor inhibitor
HU893412D0 (en) Inhibitors of interleucin-1
EP0391999A4 (en) Peptidyl inhibitors of the initiation of coagulation
TR23721A (en) USE OF ALUEMINUM CELAT COMPOUNDS AS SOFT OELDUERUECUE SUBSTANCES
ZA898553B (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
NO881215D0 (en) PROCEDURE FOR THE PREPARATION OF ALGES WITH IMPROVED BIOLOGICAL EFFECTS.
FI961378A0 (en) Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide
GB2251402B (en) Procedure for the manufacture of contour-stable objects
IT1217525B (en) PROCEDURE FOR THE PREPARATION OF CUMENE
NO893326D0 (en) PROCEDURE FOR THE NEUTRALIZATION OF SULVIC ACID CONTAINING ZINCIONS.
GB8717932D0 (en) Inhibitor of protein synthesis
EP0411395A3 (en) Use of ace inhibitors for atherosclerosis-prophylaxis
GB2219078B (en) Identifying the position of objects or zones
ZA887764B (en) Potentiation of antihypertensive effect of ace inhibitors
FI960526A (en) Process for the preparation of cumene hydroperox
GB8700950D0 (en) Treatment of super-alloy surfaces
GB8619830D0 (en) Inhibitor of protein synthesis
GB2201688B (en) The use of mixtures comprising difluorotetrachloroethane
ZA893318B (en) Agents for enhancing the growth of livestock
EP0365683A4 (en) Composition for inhibiting absorption of nucleic acid bases